Share prices are approaching a strong support area in daily data, which offers good timing for investors.
The group usually releases upbeat results with huge surprise rates.
Its low valuation, with P/E ratio at 5.85 and 12.43 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
For several months, analysts have been revising their EPS estimates roughly upwards.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The tendency within the weekly time frame is positive above the technical support level at 13.58 USD
Weaknesses
According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
